From: A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer
Patient | GTVall phases (cc) | GTVgating (cc) | Ungated GTV mobility (mm) | Residual GTV mobility (mm) |
---|---|---|---|---|
1 | 126.9 | 104.1 | 5.6 | 2.2 |
2 | 247.4 | 239.0 | 1.0 | 0.0# |
3 | 76.3 | 68.1 | 11.2 | 5.8 |
4 | 132.3 | 90.6 | 17.3 | 6.4 |
5 | 201.0 | 183.4 | 8.2 | 3.2# |
6 | 128.6 | 112.5 | 22.6 | 14.0#* |
7 | 98.4 | 66.8 | 18.2 | 5.9 |
8 | 112.7 | 81.9 | 10.9 | 2.0 |
9 | 109.8 | 79.8 | 8.4 | 1.4 |
10 | 216.3 | 193.2 | 3.0 | 2.0 |
11 | 199.8 | 162.5 | 8.7 | 4.6 |
12 | 49.7 | 44.0 | 1.0 | 1.0# |
13 | 97.7 | 89.0 | 8.4 | 6.4 |
14 | 254.0 | 239.3 | 4.6 | 1.0 |
15 | 240.7 | 193.3 | 12.6 | 3.6 |
Mean | 152.8 | 129.8 | 9.4 | 4.0 |
SD | 67.1 | 65.5 | 6.3 | 3.5 |